DIVI S LABORATORIES LTD vs Rekvina Labs Ltd

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and Rekvina Labs Ltd (REKVINALABORATORIESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs REKVINALABORATORIESLTD on 8 of 14 metrics (3 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability22
  • Growth· not comparable
  • Size & financial health30

Valuation

DIVISLAB takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

95.35
P/E ratio
0.00
10.62
P/B ratio
13.77
0.33%
Dividend yield
0.00%
₹96.73
EPS
₹-0.12

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
41.27%
22.00%
Return on capital
41.27%
33.00%
EBITDA margin
-17.91%
24.32%
Net margin
-17.91%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y) even
12.10%
Profit CAGR (3Y) even

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.43L Cr
Market cap
₹54 Cr
₹10,560 Cr
Revenue
₹0 Cr
₹2,568 Cr
Net profit
₹-0 Cr
0.00
Debt / equity even
0.00
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Rekvina Labs Ltd
  • + ["Promoter holding has increased by 35.7% over last quarter."]
  • ["Company has low interest coverage ratio."]
DIVI S LABORATORIES LTD full analysis Rekvina Labs Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.